These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34967377)

  • 1. Primary pharyngeal synovial sarcoma in a pediatric patient: A case report.
    Bae YJ; Kim H; Cha W; Choi BS
    Medicine (Baltimore); 2021 Dec; 100(52):e28411. PubMed ID: 34967377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; van Noesel MM; Brennan B; Zanetti I; Corradini N; Casanova M; Berlanga P; Merks JHM; Alaggio R; Schifflers S; Ramirez-Villar GL; Giraudo C; Burrieza GG; Safwat A; Bisogno G; De Salvo GL; Orbach D
    Lancet Child Adolesc Health; 2021 Aug; 5(8):546-558. PubMed ID: 34214481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synovial sarcoma of the parapharyngeal space.
    Khademi B; Mohammadianpanah M; Ashraf MJ; Yeganeh F
    Auris Nasus Larynx; 2007 Mar; 34(1):125-9. PubMed ID: 17056221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination effect of pirarubicin, ifosfamide, and vincristine sulfate in the treatment of advanced synovial sarcoma--report of a case].
    Shinozaki T; Matsushita M; Kusawake H; Watanabe H; Arita S; Chigira M; Udagawa E
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1389-91. PubMed ID: 7668875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of renal synovial sarcoma treated with adjuvant ifosfamide and doxorubicin.
    Ozkan EE; Mertsoylu H; Ozardali HI
    Intern Med; 2011; 50(15):1575-80. PubMed ID: 21804284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiological assessment following thermoradiation therapy for primary pleural synovial sarcoma: case report.
    Abe K; Maebayashi T; Shizukuishi T; Sakaguchi M; Furuhashi S; Takahashi M; Tanaka Y; Uematsu A; Sugitani M
    Med Oncol; 2010 Sep; 27(3):1027-30. PubMed ID: 19821063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synovial sarcoma. Case report].
    Deme D; Abdulfatah B; Telekes A
    Orv Hetil; 2016 Feb; 157(6):224-9. PubMed ID: 27120724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of renal synovial sarcoma: complete remission was induced by chemotherapy with doxorubicin and ifosfamide.
    Park SJ; Kim HK; Kim CK; Park SK; Go ES; Kim ME; Hong DS
    Korean J Intern Med; 2004 Mar; 19(1):62-5. PubMed ID: 15053047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
    Milano GM; Cozza R; Ilari I; De Sio L; Boldrini R; Jenkner A; De Ioris M; Inserra A; Dominici C; Donfrancesco A
    Cancer; 2006 Apr; 106(8):1838-45. PubMed ID: 16532434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.
    Gronchi A; Ferrari S; Quagliuolo V; Broto JM; Pousa AL; Grignani G; Basso U; Blay JY; Tendero O; Beveridge RD; Ferraresi V; Lugowska I; Merlo DF; Fontana V; Marchesi E; Donati DM; Palassini E; Palmerini E; De Sanctis R; Morosi C; Stacchiotti S; Bagué S; Coindre JM; Dei Tos AP; Picci P; Bruzzi P; Casali PG
    Lancet Oncol; 2017 Jun; 18(6):812-822. PubMed ID: 28499583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.
    Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS
    N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: a report from the Children's Oncology Group.
    Womer RB; West DC; Krailo MD; Dickman PS; Pawel BR; Grier HE; Marcus K; Sailer S; Healey JH; Dormans JP; Weiss AR
    J Clin Oncol; 2012 Nov; 30(33):4148-54. PubMed ID: 23091096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valgus and varus deformity after wide-local excision, brachytherapy and external beam irradiation in two children with lower extremity synovial cell sarcoma: case report.
    Fletcher DT; Warner WC; Neel MD; Merchant TE
    BMC Cancer; 2004 Aug; 4():57. PubMed ID: 15333137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.
    Wexler LH; DeLaney TF; Tsokos M; Avila N; Steinberg SM; Weaver-McClure L; Jacobson J; Jarosinski P; Hijazi YM; Balis FM; Horowitz ME
    Cancer; 1996 Aug; 78(4):901-11. PubMed ID: 8756388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study.
    Pappo AS; Devidas M; Jenkins J; Rao B; Marcus R; Thomas P; Gebhardt M; Pratt C; Grier HE
    J Clin Oncol; 2005 Jun; 23(18):4031-8. PubMed ID: 15767644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.
    Mullah-Ali A; Ramsay JA; Bourgeois JM; Hodson I; Macdonald P; Midia M; Portwine C
    J Pediatr Hematol Oncol; 2008 Jul; 30(7):553-7. PubMed ID: 18797206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
    Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
    J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
    Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
    Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.